Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000925421-21-000140
Filing Date
2021-06-02
Accepted
2021-06-02 19:19:42
Documents
1
Period of Report
2021-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4310
  Complete submission text file 0000925421-21-000140.txt   5672
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Issuer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address
ORTH ANDREW C. (Reporting) CIK: 0001860010 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38210 | Film No.: 21990802